Effect of the Suryanamaskar in the management of Dyslipidemia: A clinical  study

Jaideep Arya; Manju Bora

doi:10.48165/IRJAY.2023.6304

Authors

Jaideep Arya Chairman- Haryana Yog Aayog, Secretary General- National Yogasana Sports Federation, and Ph.D Scholar, Maharaja Agrasen Himalayan Garhwal University, Uttarakhand, India – 246169. Author
Manju Bora Professor, Maharaja Agrasen Himalayan Garhwal University, Uttarakhand, India . Author

DOI:

https://doi.org/10.48165/IRJAY.2023.6304

Keywords:

Yoga, Suryanamaskar, Dyslipidemia

Abstract

The purpose of the study was to find out the effect of Surya namaskar on the management of Dyslipidemia patients. To achieve this purpose, sixty (N=60) patients with Dyslipidemia were selected from Bhiwani, Haryana with their ages ranging between 21 to 57 years. They were classified into two groups i.e.; one is the control group (N=30) (Medicine + No change in their daily routine) and the other is an experimental or interventional group (N=30) (Medicine + Suryanamaskar practice 30±10 minutes/day for 5 days/week over the period of twelve weeks). Suryanamskar was assessed for all the selected subjects by an expert Yoga trainer doing an intervention programme, and the Dyslipidemia was examined by the level of Cholesterol, level of triglycerides, level of high-density Lipoprotein-s, and level of very low-density Lipoprotein-s test before and after the intervention programme and collected data were subjected to statistical treatment by using SPSS (Statistical Package of Social Sciences, version 20). In all the cases 0.05 level of confidence was fixed to test the significance. After that, in the concluding phase, the result has become significant, that depict, the Suryanamaskar training shows better improvement in the management of Dyslipidemia.

Downloads

Download data is not yet available.

References

Ahn, C. H., & Choi, S. H. (2015). New Drugs for Treating Dyslipidemia : Beyond Statins. 87–94.

Bhatia, S. K. (2010). Coronary Artery Disease Coronary. Biomaterials for Clinical Applications, 23–49.

Binkoski, A. E., Zhao, G., Coval, S. M., Clemmer, K. F., & Hecker, K. D. (2021). Dietary fat : assessing the evidence in support of a moderate-fat diet ; the benchmark based on lipoprotein metabolism. 2002, 287–298. https://doi.org/10.1079/PNS2002157

Djelilovic-Vranic, J., Alajbegovic, A., Zelija-Asimi, V., Niksic, M., Tiric-Campara, M., Salcic, S., & Celo, A. (2013). Predilection role diabetes mellitus and dyslipidemia in the onset of ischemic stroke. Medical Archives (Sarajevo, Bosnia and Herzegovina), 67(2), 120– 123. https://doi.org/10.5455/medarh.2013.67.120-123

Ebrahimi, H., Hassan, M., Hashemi, H., & Fotouhi, A. (2016). Diabetes & Metabolic Syndrome : Clinical Research & Reviews Dyslipidemia and its risk factors among urban middle-aged Iranians : A population-based study. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 1–8. https://doi.org/10.1016/j.dsx.2016.01.009

Gaggini, M., Morelli, M., Buzzigoli, E., DeFronzo, R. A., Bugianesi, E., & Gastaldelli, A. (2013). Non-alcoholic fatty liver disease (NAFLD) and its connection with insulin

resistance, dyslipidemia, atherosclerosis and coronary heart disease. Nutrients, 5(5), 1544–1560. https://doi.org/10.3390/nu5051544

Ghadir, M. R., Riahin, A. A., Havaspour, A., Nooranipour, M., & Habibinejad, A. A. (2010). The relationship between lipid profile and severity of liver damage in cirrhotic patients. Hepatitis Monthly, 10(4), 285–288.

GM, K. (2014). Role of Yoga in Chronic Kidney Disease: A Hypothetical Review. Journal of Nephrology & Therapeutics, 04(03). https://doi.org/10.4172/2161- 0959.1000167

Gupta, R., Rao, R. S., Misra, A., & Sharma, S. K. (2017). Recent trends in epidemiology of dyslipidemias in India. Indian Heart Journal, 69(3), 382–392. https://doi.org/10.1016/j.ihj.2017.02.020